LifePlan Financial’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Sell
1,144
-86
-7% -$26.1K 0.35% 69
2026
Q1
$263K Sell
1,230
-34
-3% -$7.6K 0.19% 81
2025
Q4
$216K Sell
1,264
-290
-19% -$45.1K 0.17% 85
2025
Q3
$208K Buy
+1,554
New +$165K 0.16% 82
2024
Q3
Sell
-2,090
Closed -$223K 93
2024
Q2
$223K Sell
2,090
-330
-14% -$31.6K 0.21% 88
2024
Q1
$235K Sell
2,420
-370
-13% -$32.5K 0.22% 89
2023
Q4
$219K Buy
+2,790
New +$190K 0.22% 86

Other funds holding LRCX

LifePlan Financial's LRCX Position: Q2 2026 in Review

LifePlan Financial reduced its Lam Research (LRCX) stake by 7% in Q2 2026, selling an estimated $26.1K and leaving 1,144 shares worth $496K. The position accounts for 0.35% of the portfolio, ranked #69.

LifePlan Financial first reported a position in LRCX in Q4 2023 and has held it in 7 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • LifePlan Financial held 1,144 shares of Lam Research worth $496K as of Q2 2026.
  • LifePlan Financial sold 86 Lam Research shares in Q2 2026, an estimated $26.1K.
  • Lam Research made up 0.35% of LifePlan Financial's portfolio in Q2 2026, its #69 holding.
  • LifePlan Financial first reported a position in Lam Research in Q4 2023 and has held it in 7 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on LifePlan Financial's 13F filing for Q2 2026, filed 21 Jul 2026.